Home  >  Products  >  DHTKD1 (dehydrogenase E1 and transketolase domain containing 1 ) Blocking Peptide (the N terminal of DHTKD1)(100ug)
DHTKD1 (dehydrogenase E1 and transketolase domain containing 1 ) Blocking Peptide (the N terminal of DHTKD1)(100ug)

DHTKD1 (dehydrogenase E1 and transketolase domain containing 1 ) Blocking Peptide (the N terminal of DHTKD1)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-DHTKD1 Antibody (ARP62796_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP62796
Size: 100ug
Weight: 102kDa
Gene: 55526
Format: Lyophilized powder
Target: The 2-oxoglutarate dehydrogenase complex catalyzes the overall conversion of 2-oxoglutarate to succinyl-CoA and CO2. It contains multiple copies of three enzymatic components: 2-oxoglutarate dehydrogenase (E1), dihydrolipoamide succinyltransferase (E2) and lipoamide dehydrogenase (E3).
Alternative names: DKFZp762M115; KIAA1630; MGC3090
See Full Product Listings >